This inventor holds 5 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignees: Ucbbiopharma Srl, Padlock Therapeutics, Inc.. Active years: 2021-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2026
Title: Nathaniel Julius Thomas Monck: Innovator in PAD4 Inhibition
Introduction
Nathaniel Julius Thomas Monck is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that target specific enzymes related to various disorders.
Latest Patents
Monck holds a patent for "Heteroaryl inhibitors of PAD4." This invention provides compounds that are useful as inhibitors of PAD4, along with compositions and methods for treating PAD4-related disorders. His innovative work in this area has the potential to impact therapeutic approaches significantly.
Career Highlights
Monck is associated with Padlock Therapeutics, Inc., where he applies his expertise in drug development and enzyme inhibition. His work focuses on advancing the understanding and treatment of diseases linked to PAD4.
Collaborations
Throughout his career, Monck has collaborated with talented individuals such as Rajesh Devraj and Gnanasambandam Kumaravel. These partnerships have fostered a collaborative environment that enhances research and innovation.
Conclusion
Nathaniel Julius Thomas Monck is a distinguished inventor whose work in PAD4 inhibition showcases his commitment to advancing medical science. His contributions are paving the way for new therapeutic options in treating related disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile